Inhibition of KDM5A with small molecule inhibitors such as the pan-KDM inhibitor JIB 04 and the selective KDM5A inhibitor CP1445 efficiently inhibited tumor growth in vitro and in vivo of TMZ-resistant GBM [120,121]. Here, KDM5A is linked to glioblastoma.